Literature DB >> 31791690

Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK.

Roger Williams1, Guruprasad Aithal2, Graeme J Alexander3, Michael Allison4, Iain Armstrong5, Richard Aspinall6, Alastair Baker7, Rachel Batterham8, Katrina Brown9, Robyn Burton5, Matthew E Cramp10, Natalie Day11, Anil Dhawan7, Colin Drummond12, James Ferguson13, Graham Foster14, Ian Gilmore15, Jonny Greenberg16, Clive Henn5, Helen Jarvis17, Deirdre Kelly18, Mead Mathews19, Annie McCloud20, Alastair MacGilchrist21, Martin McKee22, Kieran Moriarty23, Joanne Morling24, Philip Newsome25, Peter Rice26, Stephen Roberts27, Harry Rutter28, Marianne Samyn7, Katherine Severi29, Nick Sheron30, Douglas Thorburn31, Julia Verne5, Jyotsna Vohra32, John Williams27, Andrew Yeoman33.   

Abstract

This final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity, with high levels of hospital admissions which are worsening in deprived areas. Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures (including a minimum unit price for alcohol, the alcohol duty escalator, and an extension of the sugar levy on food content) can the disease burden be curtailed. Following introduction of minimum unit pricing in Scotland, alcohol sales fell by 3%, with the greatest effect on heavy drinkers of low-cost alcohol products. We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity-the highest of any country in the west. Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high, indicating the need to develop a masterplan for improving hospital care. We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks. This plan has received strong backing from the British Association for Study of the Liver and British Society of Gastroenterology, but is held up at NHS England. The value of so-called day-case care bundles to reduce high hospital readmission rates with greater care in the community is described, along with examples of locally derived schemes for the early detection of disease and, in particular, schemes to allow general practitioners to refer patients directly for elastography assessment. New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country. Understanding of the harm to health from lifestyle causes among the general population is low, with a poor knowledge of alcohol consumption and dietary guidelines. The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper, with the onus placed on the individual based on the use of information technology and the latest in behavioural science, will be effective. We call for greater coordination between official and non-official bodies that have highlighted the unacceptable disease burden from liver disease in England in order to present a single, strong voice to the higher echelons of government.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31791690     DOI: 10.1016/S0140-6736(19)32908-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  22 in total

1.  Construction of ceRNA network and identification of two differentially expressed circRNAs in hepatocellular carcinoma by bioinformatic analysis.

Authors:  Hongwei He; Zhong Shen; Qiyun Gu; Rong Xie
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

Review 2.  Identification of liver disease: why and how.

Authors:  Iain Macpherson; Kushala W M Abeysekera; Rebecca Harris; Dina Mansour; Stuart McPherson; Ian Rowe; William Rosenberg; John F Dillon; Andrew Yeoman
Journal:  Frontline Gastroenterol       Date:  2022-01-24

3.  The pathway to better primary care for chronic liver disease.

Authors:  Helen Jarvis; Stuart McPherson; Quentin M Anstee; Barbara Hanratty
Journal:  Br J Gen Pract       Date:  2021-03-26       Impact factor: 5.386

Review 4.  Report of the Lancet Commission on the Value of Death: bringing death back into life.

Authors:  Libby Sallnow; Richard Smith; Sam H Ahmedzai; Afsan Bhadelia; Charlotte Chamberlain; Yali Cong; Brett Doble; Luckson Dullie; Robin Durie; Eric A Finkelstein; Sam Guglani; Melanie Hodson; Bettina S Husebø; Allan Kellehear; Celia Kitzinger; Felicia Marie Knaul; Scott A Murray; Julia Neuberger; Seamus O'Mahony; M R Rajagopal; Sarah Russell; Eriko Sase; Katherine E Sleeman; Sheldon Solomon; Ros Taylor; Mpho Tutu van Furth; Katrina Wyatt
Journal:  Lancet       Date:  2022-02-01       Impact factor: 79.321

Review 5.  Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications.

Authors:  Katherine Martin; Anas Hatab; Varinder S Athwal; Elliot Jokl; Karen Piper Hanley
Journal:  Curr Diab Rep       Date:  2021-02-05       Impact factor: 4.810

6.  Decreasing Incidence of Alcohol-Related Liver Disease in Denmark: A 25-Year Nationwide Study.

Authors:  Frederik Kraglund; Thomas Deleuran; Gro Askgaard; Kate M Fleming; Peter Jepsen
Journal:  Clin Epidemiol       Date:  2021-01-07       Impact factor: 4.790

7.  Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records.

Authors:  Jonathan Pearson-Stuttard; James Bennett; Yiling J Cheng; Eszter P Vamos; Amanda J Cross; Majid Ezzati; Edward W Gregg
Journal:  Lancet Diabetes Endocrinol       Date:  2021-02-04       Impact factor: 44.867

8.  Specialist alcohol inpatient treatment admissions and non-specialist hospital admissions for alcohol withdrawal in England: an inverse relationship.

Authors:  Thomas Phillips; Chao Huang; Emmert Roberts; Colin Drummond
Journal:  Alcohol Alcohol       Date:  2021-01-04       Impact factor: 2.826

Review 9.  Protective effect of isoflavones and triterpenoid saponins from pueraria lobata on liver diseases: A review.

Authors:  Heng He; Shuwei Peng; Xu Song; Renyong Jia; Yuanfeng Zou; Lixia Li; Zhongqiong Yin
Journal:  Food Sci Nutr       Date:  2021-12-10       Impact factor: 2.863

10.  Association between behavioural risk factors for chronic liver disease and transient elastography measurements across the UK: a cross-sectional study.

Authors:  Ceyhun Aksel Oztumer; Rayhan Mehmood Chaudhry; Laith Alrubaiy
Journal:  BMJ Open Gastroenterol       Date:  2020-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.